SRRA Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: SRRA Shares Outstanding History and SRRA YTD Return |
SRRA Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: SRRA Shares Outstanding History and SRRA YTD Return |
SRRA Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||
+72.76% CAGR Mouse over chart for data details
|
SRRA Stock Price Chart |
About Sierra Oncology Inc |
Sierra Oncology is a late-stage biopharmaceutical company focused on therapies that treat cancer. Co.'s focus is the development and commercialization of momelotinib, an investigational agent for the treatment of myelofibrosis. Momelotinib is a small-molecule inhibitor of JAK1 (Janus kinase 1), JAK2 (Janus kinase 2) and ACVR1 (Activin A receptor type 1), under development for treatment of patients with myelofibrosis. Co. has conducted a review of data from the two Phase 3 trials of momelotinib, versus ruxolitinib and best available therapy, as well as GS-US-352-1672, a Phase 2, open-label, translational biology trial of momelotinib in transfusion-dependent subjects with myelofibrosis. We show 25 historical shares outstanding datapoints in our SRRA shares outstanding history coverage, used to compute SRRA market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing SRRA market cap history over the course of time is important for investors interested in comparing SRRA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of SRRA versus a peer is one thing; comparing SRRA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like SRRA can fluctuate over the course of history. With this page we aim to empower investors researching SRRA by allowing them to research the SRRA market cap history. |
SRRA Current Stock Quote |
Free SRRA Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
SRRA Share Performance |
Market Cap Peers |
Sierra Oncology (SRRA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
SRRK Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.